APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Biologics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Veterinary Biologics Industry Growth and Trends Forecast to 2032

2 January 2026123 pages

Choose your research edition.

Industry ResearchVeterinary Biologics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Biologics Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Veterinary Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Biologics Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Biologics Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Veterinary Biologics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Biologics include Avimex Animal, Bio-Labs, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, DHN, Elanco/Eli Lilly and FATRO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Veterinary Biologics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Biologics market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Biologics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Biologics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Biologics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Biologics Market by Company

Avimex Animal

Bio-Labs

Boehringer Ingelheim

CAHIC

CAVAC

Ceva

DHN

Elanco/Eli Lilly

FATRO

HVRI

Kyoto Biken

Ringpu Biology

Vaksindo

Virbac

WINSUN

Yebio

Zoetis

ChengDu Tecbond

Jinyu Bio-Technology

Merck

Veterinary Biologics Segment by Type

Vaccines

Monoclonal Antibodies

Veterinary Biologics Segment by Application

Llivestock

Equine

Other

Veterinary Biologics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vaccines Table 2. Major Company of Monoclonal Antibodies Table 3. Global Veterinary Biologics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 5. Global Veterinary Biologics Sales Market Share in Volume by Type (2021-2026) Table 6. Global Veterinary Biologics Sales by Type (2021-2026) & (US$ Million) Table 7. Global Veterinary Biologics Sales Market Share in Value by Type (2021-2026) Table 8. Global Veterinary Biologics Price by Type (2021-2026) & (US$/Unit) Table 9. Global Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 10. Global Veterinary Biologics Sales Market Share in Volume by Type (2027-2032) Table 11. Global Veterinary Biologics Sales by Type (2027-2032) & (US$ Million) Table 12. Global Veterinary Biologics Sales Market Share in Value by Type (2027-2032) Table 13. Global Veterinary Biologics Price by Type (2027-2032) & (US$/Unit) Table 14. North America Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 15. North America Veterinary Biologics Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 17. Europe Veterinary Biologics Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Veterinary Biologics Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 21. Latin America Veterinary Biologics Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Veterinary Biologics Sales by Type (2021-2026) & (US$ Million) Table 24. Veterinary Biologics Industry Trends Table 25. Veterinary Biologics Industry Drivers Table 26. Veterinary Biologics Industry Opportunities and Challenges Table 27. Veterinary Biologics Industry Restraints Table 28. Global Veterinary Biologics Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Veterinary Biologics Revenue Market Share by Company (2021-2026) Table 30. Global Veterinary Biologics Sales by Company (2021-2026) & (M Units) Table 31. Global Veterinary Biologics Sales Share by Company (2021-2026) Table 32. Global Veterinary Biologics Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Veterinary Biologics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Veterinary Biologics Major Company Production Sites and Headquarters Table 35. Global Veterinary Biologics Company, Product Type & Application Table 36. Global Veterinary Biologics Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Veterinary Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Veterinary Biologics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Veterinary Biologics Sales by Region (2021-2026) & (M Units) Table 41. Global Veterinary Biologics Sales Market Share in Volume by Region (2021-2026) Table 42. Global Veterinary Biologics Sales by Region (2021-2026) & (US$ Million) Table 43. Global Veterinary Biologics Sales Market Share in Value by Region (2021-2026) Table 44. Global Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Veterinary Biologics Sales by Region (2027-2032) & (M Units) Table 46. Global Veterinary Biologics Sales Market Share in Volume by Region (2027-2032) Table 47. Global Veterinary Biologics Sales by Region (2027-2032) & (US$ Million) Table 48. Global Veterinary Biologics Sales Market Share in Value by Region (2027-2032) Table 49. Global Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Veterinary Biologics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 52. Global Veterinary Biologics Sales Market Share in Volume by Application (2021-2026) Table 53. Global Veterinary Biologics Sales by Application (2021-2026) & (US$ Million) Table 54. Global Veterinary Biologics Sales Market Share in Value by Application (2021-2026) Table 55. Global Veterinary Biologics Price by Application (2021-2026) & (US$/Unit) Table 56. Global Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 57. Global Veterinary Biologics Sales Market Share in Volume by Application (2027-2032) Table 58. Global Veterinary Biologics Sales by Application (2027-2032) & (US$ Million) Table 59. Global Veterinary Biologics Sales Market Share in Value by Application (2027-2032) Table 60. Global Veterinary Biologics Price by Application (2027-2032) & (US$/Unit) Table 61. North America Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 62. North America Veterinary Biologics Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 64. Europe Veterinary Biologics Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Veterinary Biologics Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 68. Latin America Veterinary Biologics Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Veterinary Biologics Sales by Application (2021-2026) & (US$ Million) Table 71. Avimex Animal Company Information Table 72. Avimex Animal Business Overview Table 73. Avimex Animal Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Avimex Animal Veterinary Biologics Product Portfolio Table 75. Avimex Animal Recent Development Table 76. Bio-Labs Company Information Table 77. Bio-Labs Business Overview Table 78. Bio-Labs Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bio-Labs Veterinary Biologics Product Portfolio Table 80. Bio-Labs Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Veterinary Biologics Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. CAHIC Company Information Table 87. CAHIC Business Overview Table 88. CAHIC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. CAHIC Veterinary Biologics Product Portfolio Table 90. CAHIC Recent Development Table 91. CAVAC Company Information Table 92. CAVAC Business Overview Table 93. CAVAC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. CAVAC Veterinary Biologics Product Portfolio Table 95. CAVAC Recent Development Table 96. Ceva Company Information Table 97. Ceva Business Overview Table 98. Ceva Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Ceva Veterinary Biologics Product Portfolio Table 100. Ceva Recent Development Table 101. DHN Company Information Table 102. DHN Business Overview Table 103. DHN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. DHN Veterinary Biologics Product Portfolio Table 105. DHN Recent Development Table 106. Elanco/Eli Lilly Company Information Table 107. Elanco/Eli Lilly Business Overview Table 108. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Elanco/Eli Lilly Veterinary Biologics Product Portfolio Table 110. Elanco/Eli Lilly Recent Development Table 111. FATRO Company Information Table 112. FATRO Business Overview Table 113. FATRO Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. FATRO Veterinary Biologics Product Portfolio Table 115. FATRO Recent Development Table 116. HVRI Company Information Table 117. HVRI Business Overview Table 118. HVRI Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. HVRI Veterinary Biologics Product Portfolio Table 120. HVRI Recent Development Table 121. Kyoto Biken Company Information Table 122. Kyoto Biken Business Overview Table 123. Kyoto Biken Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Kyoto Biken Veterinary Biologics Product Portfolio Table 125. Kyoto Biken Recent Development Table 126. Ringpu Biology Company Information Table 127. Ringpu Biology Business Overview Table 128. Ringpu Biology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Ringpu Biology Veterinary Biologics Product Portfolio Table 130. Ringpu Biology Recent Development Table 131. Vaksindo Company Information Table 132. Vaksindo Business Overview Table 133. Vaksindo Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Vaksindo Veterinary Biologics Product Portfolio Table 135. Vaksindo Recent Development Table 136. Virbac Company Information Table 137. Virbac Business Overview Table 138. Virbac Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Virbac Veterinary Biologics Product Portfolio Table 140. Virbac Recent Development Table 141. WINSUN Company Information Table 142. WINSUN Business Overview Table 143. WINSUN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. WINSUN Veterinary Biologics Product Portfolio Table 145. WINSUN Recent Development Table 146. Yebio Company Information Table 147. Yebio Business Overview Table 148. Yebio Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Yebio Veterinary Biologics Product Portfolio Table 150. Yebio Recent Development Table 151. Zoetis Company Information Table 152. Zoetis Business Overview Table 153. Zoetis Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Zoetis Veterinary Biologics Product Portfolio Table 155. Zoetis Recent Development Table 156. ChengDu Tecbond Company Information Table 157. ChengDu Tecbond Business Overview Table 158. ChengDu Tecbond Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. ChengDu Tecbond Veterinary Biologics Product Portfolio Table 160. ChengDu Tecbond Recent Development Table 161. Jinyu Bio-Technology Company Information Table 162. Jinyu Bio-Technology Business Overview Table 163. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Jinyu Bio-Technology Veterinary Biologics Product Portfolio Table 165. Jinyu Bio-Technology Recent Development Table 166. Merck Company Information Table 167. Merck Business Overview Table 168. Merck Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Merck Veterinary Biologics Product Portfolio Table 170. Merck Recent Development Table 171. North America Veterinary Biologics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 172. North America Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 173. North America Veterinary Biologics Sales Market Share by Country (2021-2026) Table 174. North America Veterinary Biologics Sales Forecast by Country (2027-2032) & (M Units) Table 175. North America Veterinary Biologics Sales Market Share Forecast by Country (2027-2032) Table 176. North America Veterinary Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Veterinary Biologics Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Veterinary Biologics Market Share by Country (2021-2026) Table 179. North America Veterinary Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Veterinary Biologics Market Share Forecast by Country (2027-2032) Table 181. Europe Veterinary Biologics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 182. Europe Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 183. Europe Veterinary Biologics Sales Market Share by Country (2021-2026) Table 184. Europe Veterinary Biologics Sales Forecast by Country (2027-2032) & (M Units) Table 185. Europe Veterinary Biologics Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Veterinary Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Veterinary Biologics Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Veterinary Biologics Market Share by Country (2021-2026) Table 189. Europe Veterinary Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Veterinary Biologics Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Veterinary Biologics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 193. Asia-Pacific Veterinary Biologics Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Veterinary Biologics Sales Forecast by Country (2027-2032) & (M Units) Table 195. Asia-Pacific Veterinary Biologics Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Veterinary Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Veterinary Biologics Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Veterinary Biologics Market Share by Country (2021-2026) Table 199. Asia-Pacific Veterinary Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Veterinary Biologics Market Share Forecast by Country (2027-2032) Table 201. Latin America Veterinary Biologics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 202. Latin America Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 203. Latin America Veterinary Biologics Sales Market Share by Country (2021-2026) Table 204. Latin America Veterinary Biologics Sales Forecast by Country (2027-2032) & (M Units) Table 205. Latin America Veterinary Biologics Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Veterinary Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Veterinary Biologics Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Veterinary Biologics Market Share by Country (2021-2026) Table 209. Latin America Veterinary Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Veterinary Biologics Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Veterinary Biologics Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 213. Middle East and Africa Veterinary Biologics Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Veterinary Biologics Sales Forecast by Country (2027-2032) & (M Units) Table 215. Middle East and Africa Veterinary Biologics Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Veterinary Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Veterinary Biologics Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Veterinary Biologics Market Share by Country (2021-2026) Table 219. Middle East and Africa Veterinary Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Veterinary Biologics Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Veterinary Biologics Distributors List Table 224. Veterinary Biologics Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Veterinary Biologics Image Figure 2. Global Veterinary Biologics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Biologics Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Biologics Sales (2021-2032) & (M Units) Figure 5. Vaccines Image Figure 6. Global Vaccines Sales YoY Growth (2021-2032) & (M Units) Figure 7. Monoclonal Antibodies Image Figure 8. Global Monoclonal Antibodies Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Veterinary Biologics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Veterinary Biologics Market Share by Type 2025 VS 2032 Figure 11. North America Veterinary Biologics Sales Market Share in Volume by Type in 2025 Figure 12. North America Veterinary Biologics Sales Market Share in Value by Type in 2025 Figure 13. Europe Veterinary Biologics Sales Market Share in Volume by Type in 2025 Figure 14. Europe Veterinary Biologics Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Veterinary Biologics Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Veterinary Biologics Sales Market Share in Value by Type in 2025 Figure 17. Latin America Veterinary Biologics Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Veterinary Biologics Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Veterinary Biologics Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Veterinary Biologics Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Veterinary Biologics Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Llivestock Image Figure 24. Global Llivestock Sales YoY Growth (2021-2032) & (M Units) Figure 25. Equine Image Figure 26. Global Equine Sales YoY Growth (2021-2032) & (M Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Veterinary Biologics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Veterinary Biologics Market Share by Application 2025 VS 2032 Figure 31. North America Veterinary Biologics Sales Market Share in Volume by Application in 2025 Figure 32. North America Veterinary Biologics Sales Market Share in Value by Application in 2025 Figure 33. Europe Veterinary Biologics Sales Market Share in Volume by Application in 2025 Figure 34. Europe Veterinary Biologics Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Veterinary Biologics Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Veterinary Biologics Sales Market Share in Value by Application in 2025 Figure 37. Latin America Veterinary Biologics Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Veterinary Biologics Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Veterinary Biologics Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Veterinary Biologics Sales Market Share in Value by Application in 2025 Figure 41. North America Veterinary Biologics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Veterinary Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Veterinary Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Veterinary Biologics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Veterinary Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Veterinary Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Veterinary Biologics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Veterinary Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Veterinary Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Veterinary Biologics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Veterinary Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Veterinary Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Veterinary Biologics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Veterinary Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Veterinary Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Veterinary Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Veterinary Biologics Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Veterinary Biologics Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Monoclonal Antibodies
Applications
  • Llivestock
  • Equine
  • Other
Companies covered
  • Avimex Animal
  • Bio-Labs
  • Boehringer Ingelheim
  • CAHIC
  • CAVAC
  • Ceva
  • DHN
  • Elanco/Eli Lilly
  • FATRO
  • HVRI
  • Kyoto Biken
  • Ringpu Biology
  • Vaksindo
  • Virbac
  • WINSUN
  • Yebio
  • Zoetis
  • ChengDu Tecbond
  • Jinyu Bio-Technology
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Biologics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary Biologics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary Biologics Market by Type
  6. 1.3.1 Vaccines
  7. 1.3.2 Monoclonal Antibodies
  8. 1.4 Global Veterinary Biologics Market Size by Type
  9. 1.4.1 Global Veterinary Biologics Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Veterinary Biologics Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Veterinary Biologics Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Veterinary Biologics Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Veterinary Biologics Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Veterinary Biologics Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Veterinary Biologics Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Veterinary Biologics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary Biologics Industry Trends
  2. 2.2 Veterinary Biologics Industry Drivers
  3. 2.3 Veterinary Biologics Industry Opportunities and Challenges
  4. 2.4 Veterinary Biologics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary Biologics Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary Biologics Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary Biologics Price (2021-2026)
  4. 3.4 Global Veterinary Biologics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Biologics Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary Biologics Company, Product Type & Application
  7. 3.7 Global Veterinary Biologics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Biologics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Biologics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Biologics Tier 1, Tier 2, and Tier 3
4 Veterinary Biologics Regional Status and Outlook
  1. 4.1 Global Veterinary Biologics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary Biologics Historic Market Size by Region
  3. 4.2.1 Global Veterinary Biologics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary Biologics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary Biologics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary Biologics Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary Biologics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary Biologics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary Biologics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Biologics by Application
  1. 5.1 Veterinary Biologics Market by Application
  2. 5.1.1 Llivestock
  3. 5.1.2 Equine
  4. 5.1.3 Other
  5. 5.2 Global Veterinary Biologics Market Size by Application
  6. 5.2.1 Global Veterinary Biologics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Veterinary Biologics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Veterinary Biologics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Veterinary Biologics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Veterinary Biologics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Veterinary Biologics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Veterinary Biologics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Veterinary Biologics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Avimex Animal
  2. 6.1.1 Avimex Animal Company Information
  3. 6.1.2 Avimex Animal Business Overview
  4. 6.1.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Avimex Animal Veterinary Biologics Product Portfolio
  6. 6.1.5 Avimex Animal Recent Developments
  7. 6.2 Bio-Labs
  8. 6.2.1 Bio-Labs Company Information
  9. 6.2.2 Bio-Labs Business Overview
  10. 6.2.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bio-Labs Veterinary Biologics Product Portfolio
  12. 6.2.5 Bio-Labs Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 CAHIC
  20. 6.4.1 CAHIC Company Information
  21. 6.4.2 CAHIC Business Overview
  22. 6.4.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CAHIC Veterinary Biologics Product Portfolio
  24. 6.4.5 CAHIC Recent Developments
  25. 6.5 CAVAC
  26. 6.5.1 CAVAC Company Information
  27. 6.5.2 CAVAC Business Overview
  28. 6.5.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CAVAC Veterinary Biologics Product Portfolio
  30. 6.5.5 CAVAC Recent Developments
  31. 6.6 Ceva
  32. 6.6.1 Ceva Company Information
  33. 6.6.2 Ceva Business Overview
  34. 6.6.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ceva Veterinary Biologics Product Portfolio
  36. 6.6.5 Ceva Recent Developments
  37. 6.7 DHN
  38. 6.7.1 DHN Company Information
  39. 6.7.2 DHN Business Overview
  40. 6.7.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 DHN Veterinary Biologics Product Portfolio
  42. 6.7.5 DHN Recent Developments
  43. 6.8 Elanco/Eli Lilly
  44. 6.8.1 Elanco/Eli Lilly Company Information
  45. 6.8.2 Elanco/Eli Lilly Business Overview
  46. 6.8.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
  48. 6.8.5 Elanco/Eli Lilly Recent Developments
  49. 6.9 FATRO
  50. 6.9.1 FATRO Company Information
  51. 6.9.2 FATRO Business Overview
  52. 6.9.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 FATRO Veterinary Biologics Product Portfolio
  54. 6.9.5 FATRO Recent Developments
  55. 6.10 HVRI
  56. 6.10.1 HVRI Company Information
  57. 6.10.2 HVRI Business Overview
  58. 6.10.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 HVRI Veterinary Biologics Product Portfolio
  60. 6.10.5 HVRI Recent Developments
  61. 6.11 Kyoto Biken
  62. 6.11.1 Kyoto Biken Company Information
  63. 6.11.2 Kyoto Biken Business Overview
  64. 6.11.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kyoto Biken Veterinary Biologics Product Portfolio
  66. 6.11.5 Kyoto Biken Recent Developments
  67. 6.12 Ringpu Biology
  68. 6.12.1 Ringpu Biology Company Information
  69. 6.12.2 Ringpu Biology Business Overview
  70. 6.12.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ringpu Biology Veterinary Biologics Product Portfolio
  72. 6.12.5 Ringpu Biology Recent Developments
  73. 6.13 Vaksindo
  74. 6.13.1 Vaksindo Company Information
  75. 6.13.2 Vaksindo Business Overview
  76. 6.13.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Vaksindo Veterinary Biologics Product Portfolio
  78. 6.13.5 Vaksindo Recent Developments
  79. 6.14 Virbac
  80. 6.14.1 Virbac Company Information
  81. 6.14.2 Virbac Business Overview
  82. 6.14.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Virbac Veterinary Biologics Product Portfolio
  84. 6.14.5 Virbac Recent Developments
  85. 6.15 WINSUN
  86. 6.15.1 WINSUN Company Information
  87. 6.15.2 WINSUN Business Overview
  88. 6.15.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 WINSUN Veterinary Biologics Product Portfolio
  90. 6.15.5 WINSUN Recent Developments
  91. 6.16 Yebio
  92. 6.16.1 Yebio Company Information
  93. 6.16.2 Yebio Business Overview
  94. 6.16.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Yebio Veterinary Biologics Product Portfolio
  96. 6.16.5 Yebio Recent Developments
  97. 6.17 Zoetis
  98. 6.17.1 Zoetis Company Information
  99. 6.17.2 Zoetis Business Overview
  100. 6.17.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Zoetis Veterinary Biologics Product Portfolio
  102. 6.17.5 Zoetis Recent Developments
  103. 6.18 ChengDu Tecbond
  104. 6.18.1 ChengDu Tecbond Company Information
  105. 6.18.2 ChengDu Tecbond Business Overview
  106. 6.18.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
  108. 6.18.5 ChengDu Tecbond Recent Developments
  109. 6.19 Jinyu Bio-Technology
  110. 6.19.1 Jinyu Bio-Technology Company Information
  111. 6.19.2 Jinyu Bio-Technology Business Overview
  112. 6.19.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
  114. 6.19.5 Jinyu Bio-Technology Recent Developments
  115. 6.20 Merck
  116. 6.20.1 Merck Company Information
  117. 6.20.2 Merck Business Overview
  118. 6.20.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Merck Veterinary Biologics Product Portfolio
  120. 6.20.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary Biologics Sales by Country
  2. 7.1.1 North America Veterinary Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary Biologics Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary Biologics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary Biologics Market Size by Country
  6. 7.2.1 North America Veterinary Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary Biologics Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary Biologics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary Biologics Sales by Country
  2. 8.1.1 Europe Veterinary Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary Biologics Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary Biologics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary Biologics Market Size by Country
  6. 8.2.1 Europe Veterinary Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary Biologics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary Biologics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary Biologics Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary Biologics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary Biologics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary Biologics Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary Biologics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary Biologics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary Biologics Sales by Country
  2. 10.1.1 South America Veterinary Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary Biologics Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary Biologics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary Biologics Market Size by Country
  6. 10.2.1 South America Veterinary Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary Biologics Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary Biologics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary Biologics Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary Biologics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary Biologics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary Biologics Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary Biologics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary Biologics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary Biologics Value Chain Analysis
  2. 12.1.1 Veterinary Biologics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary Biologics Production Mode & Process
  7. 12.2 Veterinary Biologics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary Biologics Distributors
  10. 12.2.3 Veterinary Biologics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst